Financhill
Buy
54

CW Quote, Financials, Valuation and Earnings

Last price:
$324.12
Seasonality move :
2.45%
Day range:
$320.82 - $331.49
52-week range:
$241.44 - $393.40
Dividend yield:
0.25%
P/E ratio:
31.17x
P/S ratio:
4.04x
P/B ratio:
5.06x
Volume:
302.2K
Avg. volume:
338.8K
1-year change:
35.42%
Market cap:
$12.4B
Revenue:
$3.1B
EPS (TTM):
$10.55

Earnings Data

Next earnings date for CW
May 01
2025
Most recent earnings per share
$3.09
Beat by $0.00
(Feb 12/2025)
Consensus Estimate
$3.09
(Feb 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CW Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/01/2025 Q1 $765.9M -- -- $2.46 --
02/12/2025 Q4 $787M $824.3M $3.09 $3.09 $0.00
10/30/2024 Q3 $757.7M $798.9M $2.89 $2.69 $0.20
08/07/2024 Q2 $735.8M $784.8M $2.58 $2.29 $0.29
05/01/2024 Q1 $664M $713.2M $1.99 $1.72 $0.27
02/14/2024 Q4 $737.1M $785.8M $3.11 $2.92 $0.19
11/01/2023 Q3 -- -- $2.51 $2.38 $0.13
08/02/2023 Q2 -- -- $2.10 $1.98 $0.12
05/03/2023 Q1 -- -- $1.48 $1.40 $0.08
02/21/2023 Q4 -- -- $2.82 $2.91 -$0.09
11/02/2022 Q3 -- -- $1.91 $2.02 -$0.11
08/03/2022 Q2 -- -- $1.83 $1.69 $0.14
05/04/2022 Q1 -- -- $1.05 $1.20 -$0.15
02/23/2022 Q4 -- -- $1.94 $2.37 -$0.43
11/03/2021 Q3 -- -- $1.70 $1.82 -$0.12
08/04/2021 Q2 -- -- $1.49 $1.54 -$0.05
05/05/2021 Q1 -- -- $1.45 $1.30 $0.15
02/24/2021 Q4 -- -- $1.30 $2.34 -$1.04
10/28/2020 Q3 -- -- $1.55 $1.54 $0.01
08/03/2020 Q2 -- -- $0.74 $1.28 -$0.54
05/06/2020 Q1 -- -- $1.21 $1.29 -$0.08
02/26/2020 Q4 -- -- $2.08 $2.08 $0.00
10/30/2019 Q3 -- -- $1.92 $1.83 $0.09
07/31/2019 Q2 -- -- $1.86 $1.77 $0.09
05/08/2019 Q1 -- -- $1.29 $1.16 $0.13
02/26/2019 Q4 -- -- $1.89 $1.75 $0.14
10/30/2018 Q3 -- -- $1.68 -- --
07/25/2018 Q2 -- -- $1.68 -- --
05/02/2018 Q1 -- -- $0.98 -- --
02/21/2018 Q4 -- -- $1.52 -- --
10/25/2017 Q3 -- -- $1.43 -- --
07/26/2017 Q2 -- -- $1.13 -- --
05/03/2017 Q1 -- -- $0.73 -- --
02/15/2017 Q4 -- -- $1.53 -- --
10/27/2016 Q3 -- -- $1.02 -- --
07/28/2016 Q2 -- -- $0.88 -- --
05/04/2016 Q1 -- -- $0.73 -- --
02/24/2016 Q4 -- -- $1.51 -- --
10/28/2015 Q3 -- -- $0.71 -- --
07/29/2015 Q2 -- -- $0.53 -- --
04/29/2015 Q1 -- -- $0.33 -- --

Curtiss-Wright Earnings Questions

  • How Much did Curtiss-Wright Generate in Revenue Last Quarter?

    Curtiss-Wright reported $824.3M worth of top line sales in its most recent quarter.

  • Did Curtiss-Wright Beat Earnings Last Quarter?

    Curtiss-Wright announced earnings per share of $3.09 which represents a beat of analyst forecast a $3.09 per share.

  • Is Curtiss-Wright Profitable?

    Curtiss-Wright reported $317.4M that represents $8.32 per share over the last quarter.

  • What is the Analyst Consensus for Curtiss-Wright EPS Next Year?

    Curtiss-Wright's earnings are forecast to grow from $10.55 per share to $10.73 per share next year representing an increase of 16.86%.

  • When is Curtiss-Wright's Earnings Date?

    Curtiss-Wright's next earnings date is May 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock